Diamond Hill Capital's MDT Position Overview
Diamond Hill Capital (via Diamond Hill Capital Management INC) currently holds 2.31 M shares of Medtronic plc (MDT) worth $221.67 M, representing 1.14% of the portfolio. First purchased in 2014-Q4, this long-term strategic position has been held for 45 quarters.
Based on 13F filings since 2013, Diamond Hill Capital has maintained a long-term strategic position in MDT, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2017, adding 762,008 shares. Largest reduction occurred in Q1 2025, reducing 1.11 M shares.
Analysis based on 13F filings available since 2013 Q2
Diamond Hill Capital's Medtronic plc (MDT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Medtronic plc (MDT) Trades by Diamond Hill Capital
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -423,819 | Reduce 15.52% | 2.31 M | $96.06 |
| Q3 2025 | -203,087 | Reduce 6.92% | 2.73 M | $95.24 |
| Q2 2025 | -148,508 | Reduce 4.82% | 2.93 M | $87.17 |
| Q1 2025 | -1.11 M | Reduce 26.45% | 3.08 M | $89.86 |
| Q4 2024 | +525,877 | Add 14.34% | 4.19 M | $79.88 |
| Q3 2024 | -23,340 | Reduce 0.63% | 3.67 M | $90.03 |
| Q2 2024 | -259,059 | Reduce 6.56% | 3.69 M | $78.71 |
| Q1 2024 | +48,080 | Add 1.23% | 3.95 M | $87.15 |
| Q4 2023 | +177,692 | Add 4.77% | 3.9 M | $82.38 |
| Q3 2023 | +161,357 | Add 4.53% | 3.72 M | $78.36 |
| Q2 2023 | -10,794 | Reduce 0.30% | 3.56 M | $88.10 |
| Q1 2023 | +31,230 | Add 0.88% | 3.57 M | $80.62 |
| Q4 2022 | -134,828 | Reduce 3.67% | 3.54 M | $77.72 |
| Q3 2022 | +15,640 | Add 0.43% | 3.68 M | $80.75 |
| Q2 2022 | -450,789 | Reduce 10.97% | 3.66 M | $89.75 |
| Q1 2022 | +53,052 | Add 1.31% | 4.11 M | $110.95 |
| Q4 2021 | -534,888 | Reduce 11.65% | 4.06 M | $103.45 |
| Q3 2021 | -8,245 | Reduce 0.18% | 4.59 M | $125.35 |
| Q2 2021 | +259,981 | Add 5.99% | 4.6 M | $124.13 |
| Q1 2021 | +514,206 | Add 13.44% | 4.34 M | $118.13 |
| Q4 2020 | +170,386 | Add 4.66% | 3.83 M | $117.14 |
| Q3 2020 | -16,019 | Reduce 0.44% | 3.66 M | $103.92 |
| Q2 2020 | +27,130 | Add 0.74% | 3.67 M | $91.70 |
| Q1 2020 | -12,350 | Reduce 0.34% | 3.65 M | $90.18 |
| Q4 2019 | -103,592 | Reduce 2.75% | 3.66 M | $113.45 |
| Q3 2019 | -105,463 | Reduce 2.73% | 3.76 M | $108.62 |
| Q2 2019 | -44,775 | Reduce 1.14% | 3.87 M | $97.39 |
| Q1 2019 | +25,556 | Add 0.66% | 3.91 M | $91.08 |
| Q4 2018 | -820 | Reduce 0.02% | 3.89 M | $90.96 |
| Q3 2018 | -132,023 | Reduce 3.29% | 3.89 M | $98.37 |
| Q2 2018 | -208,705 | Reduce 4.94% | 4.02 M | $85.61 |
| Q1 2018 | +161,270 | Add 3.97% | 4.23 M | $80.22 |
| Q4 2017 | +624,370 | Add 18.14% | 4.07 M | $80.75 |
| Q3 2017 | +762,008 | Add 28.44% | 3.44 M | $77.77 |
| Q2 2017 | +81,830 | Add 3.15% | 2.68 M | $88.75 |
| Q1 2017 | -17,540 | Reduce 0.67% | 2.6 M | $80.56 |
| Q4 2016 | +229,489 | Add 9.62% | 2.62 M | $71.23 |
| Q3 2016 | -84,392 | Reduce 3.42% | 2.39 M | $86.40 |
| Q2 2016 | -44,958 | Reduce 1.79% | 2.47 M | $86.77 |
| Q1 2016 | -920,934 | Reduce 26.80% | 2.52 M | $75.00 |
| Q4 2015 | -30,267 | Reduce 0.87% | 3.44 M | $76.92 |
| Q3 2015 | -84,064 | Reduce 2.37% | 3.47 M | $66.94 |
| Q2 2015 | -16,174 | Reduce 0.45% | 3.55 M | $74.10 |
| Q1 2015 | -111,686 | Reduce 3.04% | 3.57 M | $77.99 |
| Q4 2014 | +3.68 M | New Buy | 3.68 M | $72.20 |
Diamond Hill Capital's Medtronic plc Investment FAQs
Diamond Hill Capital first purchased Medtronic plc (MDT) in Q4 2014, acquiring 3,678,388 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Diamond Hill Capital has held Medtronic plc (MDT) for 45 quarters since Q4 2014.
Diamond Hill Capital's largest addition to Medtronic plc (MDT) was in Q4 2014, adding 3,678,388 shares worth $265.58 M.
According to the latest 13F filing for Q4 2025, Diamond Hill Capital's firm, Diamond Hill Capital Management INC, owns 2,307,586 shares of Medtronic plc (MDT), valued at approximately $221.67 M.
As of the Q4 2025 filing, Medtronic plc (MDT) represents approximately 1.14% of Diamond Hill Capital's publicly disclosed stock portfolio, making it one of their key holdings.
Diamond Hill Capital's peak holding in Medtronic plc (MDT) was 4,600,852 shares, as reported at the end of Q2 2021.